Endocrinology of the stress response.
暂无分享,去创建一个
Evangelia Charmandari | C. Tsigos | G. Chrousos | E. Charmandari | George Chrousos | Constantine Tsigos
[1] P. Deuster,et al. Exercise and Circadian Rhythm-Induced Variations in Plasma Cortisol Differentially Regulate Interleukin-1β (IL-1β), IL-6, and Tumor Necrosis Factor-α (TNFα) Production in Humans: High Sensitivity of TNFα and Resistance of IL-6 , 1997 .
[2] D. Boumpas,et al. Glucocorticoid Therapy for Immune-Mediated Diseases: Basic and Clinical Correlates , 1993, Annals of Internal Medicine.
[3] J. Calabrese,et al. Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications. , 1986, The New England journal of medicine.
[4] D. Matthews,et al. Reversibility of physiological growth hormone secretion in children with psychosocial dwarfism , 1994 .
[5] G. Chrousos,et al. Elevated cerebrospinal fluid levels of immunoreactive corticotropin-releasing hormone in anorexia nervosa: relation to state of nutrition, adrenal function, and intensity of depression. , 1987, The Journal of clinical endocrinology and metabolism.
[6] G. Bray,et al. Neuropeptide Y suppresses sympathetic activity to interscapular brown adipose tissue in rats. , 1991, The American journal of physiology.
[7] G. Chrousos,et al. Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[8] R. Young,et al. Diabetic neuropathy is associated with increased activity of the hypothalamic-pituitary-adrenal axis. , 1993, The Journal of clinical endocrinology and metabolism.
[9] Y. Taché,et al. Interleukin 1β inhibits gastric emptying in rats: Mediation through prostaglandin and corticotropin-releasing factor , 1994 .
[10] G. Chrousos,et al. Interaction between GABAergic neurotransmission and rat hypothalamic corticotropin-releasing hormone secretion in vitro , 1988, Brain Research.
[11] G. Chrousos,et al. Chronic effects of a nonpeptide corticotropin-releasing hormone type I receptor antagonist on pituitary-adrenal function, body weight, and metabolic regulation. , 1998, Endocrinology.
[12] G. Chrousos. The Future of Pediatric and Adolescent Endocrinology , 1997, Annals of the New York Academy of Sciences.
[13] M. Palkovits,et al. Decreased central and peripheral catecholaminergic activation in obese Zucker rats. , 1995, Endocrinology.
[14] I. Clarke,et al. Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. II. The central noradrenergic and neuropeptide Y pathways cause immediate and prolonged hypothalamic-pituitary-adrenal activation. Potential involvement , 1994, The Journal of clinical investigation.
[15] G. Kingsley,et al. Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. , 1992, Arthritis and rheumatism.
[16] G. Chrousos,et al. Hormonal regulation of human corticotropin-releasing hormone gene expression: implications for the stress response and immune/inflammatory reaction. , 1994, Endocrine reviews.
[17] P. J. Larsen,et al. Substance P Inhibits the Release of Anterior Pituitary Adrenocorticotrophin via a Central Mechanism Involving Corticotrophin‐Releasing Factor‐Containing Neurons in the Hypothalamic Paraventricular Nucleus , 1993, Journal of neuroendocrinology.
[18] G. Chrousos,et al. Interactions between the Hypothalamic-Pituitary-Adrenal Axis and the Female Reproductive System: Clinical Implications , 1998, Annals of Internal Medicine.
[19] M. Meaney,et al. The role of the medial prefrontal cortex (cingulate gyrus) in the regulation of hypothalamic-pituitary-adrenal responses to stress , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[20] G. Chrousos,et al. Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[21] R. Pasquali,et al. The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution. , 1993, The Journal of clinical endocrinology and metabolism.
[22] O. Cameron,et al. Blunted growth hormone response to clonidine in patients with generalized anxiety disorder. , 1991, Archives of general psychiatry.
[23] T. Gray. 3 – Amygdala: Role in Autonomic and Neuroendocrine Responses to Stress , 1991 .
[24] I. Heuser,et al. Human CRH stimulation response during acute withdrawal and after medium-term abstention from alcohol abuse , 1989, Psychoneuroendocrinology.
[25] B. Chipps,et al. Reduction of serum testosterone levels during chronic glucocorticoid therapy. , 1986, Annals of internal medicine.
[26] S. Suomi,et al. Early stress and adult emotional reactivity in rhesus monkeys. , 1991, Ciba Foundation symposium.
[27] G. Chrousos,et al. Hypothalamic corticotropin-releasing hormone suppression during the postpartum period: implications for the increase in psychiatric manifestations at this time. , 1996, The Journal of clinical endocrinology and metabolism.
[28] G. Chrousos,et al. Stress Hormones, Th1/Th2 patterns, Pro/Anti-inflammatory Cytokines and Susceptibility to Disease , 1999, Trends in Endocrinology & Metabolism.
[29] T. H. Holmes,et al. Life change and onset of illness. , 1977, The Medical clinics of North America.
[30] T. Bouchard,et al. Genes, environment, and personality. , 1994, Science.
[31] U. Ehlert,et al. Psychoneuroendocrinological contributions to the etiology of depression, posttraumatic stress disorder, and stress-related bodily disorders: the role of the hypothalamus–pituitary–adrenal axis , 2001, Biological Psychology.
[32] T. Pedrazzini,et al. Chronic administration of neuropeptide Y into the lateral ventricle of C57BL/6J male mice produces an obesity syndrome including hyperphagia, hyperleptinemia, insulin resistance, and hypogonadism , 2001, Molecular and Cellular Endocrinology.
[33] F. Mora,et al. Involvement of α- and β-adrenoreceptors in the central action of norepinephrine on temperature, metabolism, heart and respiratory rates of the conscious primate , 1983, Brain Research Bulletin.
[34] G. Aguilera,et al. Participation of alpha 1-adrenergic receptors in the secretion of hypothalamic corticotropin-releasing hormone during stress. , 1992, Neuroendocrinology.
[35] G. Chrousos,et al. In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation. , 1996, Endocrinology.
[36] G. Chrousos,et al. Mechanisms of serotonin receptor agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the rat. , 1990, Endocrinology.
[37] G. Chrousos. The role of stress and the hypothalamic–pituitary–adrenal axis in the pathogenesis of the metabolic syndrome: neuro-endocrine and target tissue-related causes , 2000, International Journal of Obesity.
[38] A Barkan,et al. Decreased hypothalamic gonadotropin-releasing hormone secretion in male marathon runners. , 1986, The New England journal of medicine.
[39] J. Norton,et al. Pulsatile activation of the hypothalamic-pituitary-adrenal axis during major surgery. , 1992, Metabolism: clinical and experimental.
[40] G. Chrousos. Regulation and dysregulation of the hypothalamic-pituitary-adrenal axis. The corticotropin-releasing hormone perspective. , 1992, Endocrinology and metabolism clinics of North America.
[41] G. Aghajanian,et al. alpha 2-adrenoceptor-mediated hyperpolarization of locus coeruleus neurons: intracellular studies in vivo. , 1982, Science.
[42] T. Begenisich,et al. Regulation of fluid and electrolyte secretion in salivary gland acinar cells. , 2005, Annual review of physiology.
[43] D. London,et al. PATTERNS OF ACTH AND CORTISOL PULSATILITY OVER TWENTY‐FOUR HOURS IN NORMAL MALES AND FEMALES , 1990, Clinical endocrinology.
[44] G. Chrousos,et al. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. , 1992, JAMA.
[45] G. Benker,et al. Tsh Secretion In Cushing's Syndrome: Relation To Glucocorticoid Excess, Diabetes, Goitre, And The ‘Sick Euthyroid Syndrome’ , 1990, Clinical endocrinology.
[46] K. Malik,et al. Neuropeptide Y inhibits adrenergic transmitter release in cultured rat superior cervical ganglion cells by restricting the availability of calcium through a pertussis toxin-sensitive mechanism , 1994, Neuroscience.
[47] R. Roth,et al. Stress and the Mesocorticolimbic Dopamine Systems a , 1988, Annals of the New York Academy of Sciences.
[48] R. Fuller. Serotonin receptors involved in regulation of pituitary-adrenocortical function in rats , 1995, Behavioural Brain Research.
[49] R. Bonsall,et al. Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. , 2000, JAMA.
[50] G. Chrousos,et al. Functional characteristics of CRH receptors and potential clinical applications of CRH-receptor antagonists , 2002, Trends in Endocrinology & Metabolism.
[51] Paul Ky,et al. Neuroendocrine signals in the regulation of gonadotropin-releasing hormone secretion. , 1997 .
[52] B. Burguera,et al. Dual and selective actions of glucocorticoids upon basal and stimulated growth hormone release in man. , 1990, Neuroendocrinology.
[53] B. Jeanrenaud,et al. CNS-periphery relationships and body weight homeostasis: influence of the glucocorticoid status , 2000, International Journal of Obesity.
[54] G. Chrousos,et al. Suppressed spontaneous and stimulated growth hormone secretion in patients with Cushing's disease before and after surgical cure. , 1994, The Journal of clinical endocrinology and metabolism.
[55] W. P. Chen,et al. Corticotropin-releasing factor synapses within the paraventricular nucleus of the hypothalamus. , 1989, Neuroendocrinology.
[56] G. Chrousos,et al. Glucocorticoid and mineralocorticoid resistance/hypersensitivity syndromes. , 2001, The Journal of endocrinology.
[57] L. Aarden,et al. The relation among stress, adrenalin, interleukin 6 and acute phase proteins in the rat. , 1990, Clinical immunology and immunopathology.
[58] G. Chrousos,et al. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states , 2002, Molecular Psychiatry.
[59] J. Ottenweller,et al. Adrenal innervation may be an extrapituitary mechanism able to regulate adrenocortical rhythmicity in rats. , 1982, Endocrinology.
[60] P. Hindmarsh,et al. Direct effects of corticotrophin‐releasing hormone on stimulated growth hormone secretion , 1998, Clinical endocrinology.
[61] A Luger,et al. Acute hypothalamic-pituitary-adrenal responses to the stress of treadmill exercise. Physiologic adaptations to physical training. , 1987, The New England journal of medicine.
[62] G. Chrousos,et al. Basic and clinical studies with corticotropin-releasing hormone. Implications for a possible role in panic disorder. , 1988, The Psychiatric clinics of North America.
[63] A. Imperato,et al. Changes in brain dopamine and acetylcholine release during and following stress are independent of the pituitary-adrenocortical axis , 1991, Brain Research.
[64] G. Chrousos,et al. Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. , 1993, The Journal of clinical endocrinology and metabolism.
[65] G. Chrousos,et al. Catecholamine effects upon rat hypothalamic corticotropin-releasing hormone secretion in vitro. , 1988, The Journal of clinical investigation.
[66] G. Chrousos,et al. Transcriptional and Translational Regulation of the Splicing Isoforms of the Growth Hormone Receptor by Glucocorticoids , 2003, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[67] G. Gillies,et al. Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin , 1982, Nature.
[68] M. Owen,et al. The genetic basis of complex human behaviors. , 1994, Science.
[69] K. Catt,et al. Magnocellular axons in passage through the median eminence release vasopressin , 1986, Nature.
[70] G. Chrousos,et al. Multiple feedback regulatory loops upon rat hypothalamic corticotropin-releasing hormone secretion. Potential clinical implications. , 1988, The Journal of clinical investigation.
[71] G. Chrousos,et al. THE HYPOTHALAMIC‐PITUITARY‐ADRENAL AXIS IN INFANTILE MALNUTRITION , 1990, Clinical endocrinology.
[72] C. Tsigos,et al. Physiology of the hypothalamic-pituitary-adrenal axis in health and dysregulation in psychiatric and autoimmune disorders. , 1994, Endocrinology and metabolism clinics of North America.
[73] G. Chrousos,et al. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. , 1995, The New England journal of medicine.
[74] G. Chrousos,et al. Neuroendocrinology of stress. , 2001, Endocrinology and metabolism clinics of North America.
[75] D. Skuse,et al. A new stress-related syndrome of growth failure and hyperphagia in children, associated with reversibility of growth-hormone insufficiency , 1996, The Lancet.
[76] G. Chrousos,et al. Final stature in patients with endogenous Cushing's syndrome. , 1994, The Journal of clinical endocrinology and metabolism.
[77] B. D. Rodgers,et al. Hypophysectomy or Adrenalectomy of Rats with Insulin-Dependent Diabetes Mellitus Partially Restores Their Responsiveness to Growth Hormone , 1994, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[78] G. Chrousos,et al. Clinical review 104: Adrenocorticotropin (ACTH)- and non-ACTH-mediated regulation of the adrenal cortex: neural and immune inputs. , 1999, The Journal of clinical endocrinology and metabolism.
[79] N. Holbrook,et al. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. , 1984, Endocrine reviews.
[80] D. Wied,et al. Autonomic and behavioral effects of centrally administered corticotropin-releasing factor in rats. , 1991, Endocrinology.
[81] M L Johnson,et al. Amplitude, but not frequency, modulation of adrenocorticotropin secretory bursts gives rise to the nyctohemeral rhythm of the corticotropic axis in man. , 1990, The Journal of clinical endocrinology and metabolism.
[82] M. D. De Bellis,et al. Urinary catecholamine excretion in sexually abused girls. , 1994, Journal of the American Academy of Child and Adolescent Psychiatry.
[83] G. Chrousos,et al. Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. , 1996, Endocrine reviews.
[84] M. Dallman,et al. Corticosteroid inhibition of ACTH secretion. , 1984, Endocrine reviews.
[85] G. Mazzocchi,et al. Direct secretagogue effect of corticotropin-releasing factor on the rat adrenal cortex: the involvement of the zona medullaris. , 1992, Endocrinology.
[86] A. Dobs,et al. Alterations in the hypothalamic-pituitary-adrenal axis in actively drinking alcoholics. , 1991, The Journal of clinical endocrinology and metabolism.
[87] R. Stark,et al. Elevated levels of umbilical cord plasma corticotropin-releasing hormone in growth-retarded fetuses. , 1993, The Journal of clinical endocrinology and metabolism.
[88] K. Catt,et al. Mechanisms of Action of CRF and Other Regulators of ACTH Release in Pituitary Corticotrophs , 1987, Annals of the New York Academy of Sciences.
[89] G. Chrousos,et al. Hypothalamic-pituitary-adrenal axis dysregulation in sexually abused girls. , 1994, The Journal of clinical endocrinology and metabolism.
[90] D. Papanicolaou,et al. Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. , 1996, Proceedings of the Association of American Physicians.
[91] A. Herz,et al. Stimulation of hypothalamic β-endorphin and dynorphin release by corticotropin-releasing factor (in vitro) , 1986, Brain Research.
[92] K. Rahmouni,et al. Leptin signaling pathways in the central nervous system: interactions between neuropeptide Y and melanocortins. , 2001, BioEssays : news and reviews in molecular, cellular and developmental biology.
[93] G. Chrousos,et al. Hypothalamic-pituitary-adrenal axis activation and stimulation of systemic vasopressin secretion by recombinant interleukin-6 in humans: potential implications for the syndrome of inappropriate vasopressin secretion. , 1994, The Journal of clinical endocrinology and metabolism.
[94] G. Chrousos,et al. Bone mineral density in women with depression. , 1996, The New England journal of medicine.
[95] S. Foote,et al. Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus , 1983, Brain Research.
[96] G. Chrousos,et al. The pituitary corticotroph is not the rate limiting step in the postoperative recovery of the hypothalamic-pituitary-adrenal axis in patients with Cushing syndrome. , 1993, The Journal of clinical endocrinology and metabolism.
[97] W. Vale,et al. CRF and CRF receptors: role in stress responsivity and other behaviors. , 2004, Annual review of pharmacology and toxicology.
[98] M. Demitrack,et al. Evidence for and Pathophysiologic Implications of Hypothalamic‐Pituitary‐Adrenal Axis Dysregulation in Fibromyalgia and Chronic Fatigue Syndrome , 1998, Annals of the New York Academy of Sciences.
[99] G. Chrousos,et al. Evidence of direct estrogenic regulation of human corticotropin-releasing hormone gene expression. Potential implications for the sexual dimophism of the stress response and immune/inflammatory reaction. , 1993, The Journal of clinical investigation.
[100] D. English,et al. HAEMODYNAMIC AND NEUROENDOCRINE CONSEQUENCES OF STOPPING SMOKING‐A CONTROLLED STUDY , 1984, Clinical and experimental pharmacology & physiology.
[101] L. Fisher,et al. Modulation of central nervous system actions of corticotropin-releasing factor by dynorphin-related peptides , 1989, Brain Research.
[102] G. Chrousos,et al. The ovine corticotropin-releasing hormone-stimulation test in type I diabetic patients and controls: suggestion of mild chronic hypercortisolism. , 1993, Metabolism: clinical and experimental.
[103] D. Drossman,et al. Sexual and physical abuse in women with functional or organic gastrointestinal disorders. , 1990, Annals of internal medicine.
[104] M. Tancer,et al. Evidence for hypothalamo-growth hormone dysfunction in panic disorder: profile of growth hormone (GH) responses to clonidine, yohimbine, caffeine, glucose, GRF and TRH in panic disorder patients versus healthy volunteers. , 1992, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.
[105] A. Iranmanesh,et al. Intensive venous sampling paradigms disclose high frequency adrenocorticotropin release episodes in normal men. , 1990, The Journal of clinical endocrinology and metabolism.
[106] G. Chrousos,et al. IL-12, TNF-alpha, and hormonal changes during late pregnancy and early postpartum: implications for autoimmune disease activity during these times. , 2001, The Journal of clinical endocrinology and metabolism.
[107] Peter J. Munson,et al. Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[108] B. Bonaz,et al. Role of CRF in Stress‐Related Alterations of Gastric and Colonic Motor Function a , 1993, Annals of the New York Academy of Sciences.
[109] W. Vale,et al. Stress-induced inhibition of reproductive functions: role of endogenous corticotropin-releasing factor. , 1986, Science.
[110] F. Goodwin,et al. Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (2) , 1988, The New England journal of medicine.